Secukinumab 150 mg (2 injections per dose ( DrugBank: Secukinumab )

1 disease

ID	Disease name (Link within this page)	Number of trials
269	Pyogenic arthritis	1

269. Pyogenic arthritis

Clinical trials : 23 / Drugs : 30 - (DrugBank : 12) / Drug target genes : 15 - Drug target pathways : 106

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04274166 (ClinicalTrials.gov)	May 2021	12/2/2020	Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum	The Efficacy and Safety of Secukinumab for the Inflammatory Phase of Pyoderma Gangrenosum	Pyoderma Gangrenosum	Drug: secukinumab 150 mg (2 injections per dose	Wake Forest University Health Sciences	Novartis	Withdrawn	18 Years	75 Years	All	0	Phase 2	United States

First Previous1Next Last